Delineating the Role of GxxxG Motif in Amyloidogenesis: A New Perspective in Targeting Amyloid-Beta Mediated AD Pathogenesis

[1]  Axel Abelein.  Metal Binding of Alzheimer’s Amyloid-β and Its Effect on Peptide Self-Assembly , 2023, Accounts of chemical research.

[2]  A. Hahn,et al.  Differential pairing of transmembrane domain GxxxG dimerization motifs defines two HLA-DR MHC class II conformers , 2023, The Journal of biological chemistry.

[3]  C. Satriano,et al.  GxxxG Motif Stabilize Ion-Channel like Pores through Cα―H···O Interaction in Aβ (1-40) , 2023, International journal of molecular sciences.

[4]  M. Zacharias,et al.  An internal docking site stabilizes substrate binding to γ-secretase: Analysis by Molecular Dynamics Simulations. , 2022, Biophysical journal.

[5]  J. Collinge,et al.  Structural differences in amyloid-β fibrils from brains of nondemented elderly individuals and Alzheimer's disease patients , 2021, Proceedings of the National Academy of Sciences.

[6]  Batuhan Kav,et al.  Disorder-to-order transition of the amyloid-β peptide upon lipid binding. , 2021, Biophysical chemistry.

[7]  R. Kar,et al.  Solvent Relaxation NMR: A Tool for Real-Time Monitoring Water Dynamics in Protein Aggregation Landscape. , 2021, ACS chemical neuroscience.

[8]  D. Glebe,et al.  Mutational Analysis of the GXXXG/A Motifs in the Human Na+/Taurocholate Co-Transporting Polypeptide NTCP on Its Bile Acid Transport Function and Hepatitis B/D Virus Receptor Function , 2021, Frontiers in Molecular Biosciences.

[9]  Bikash R. Sahoo,et al.  Lipid-Chaperone Hypothesis: A Common Molecular Mechanism of Membrane Disruption by Intrinsically Disordered Proteins. , 2020, ACS chemical neuroscience.

[10]  U. Morbiducci,et al.  Aminoacid substitutions in the glycine zipper affect the conformational stability of amyloid beta fibrils , 2020, Journal of biomolecular structure & dynamics.

[11]  M. Sharifzadeh,et al.  Design of peptide-based inhibitor agent against amyloid-β aggregation: Molecular docking, synthesis and in vitro evaluation. , 2020, Bioorganic chemistry.

[12]  A. K. Mandal,et al.  Comparison of Synthetic Neuronal Model Membrane Mimics in Amyloid Aggregation at Atomic Resolution. , 2020, ACS chemical neuroscience.

[13]  T. Govindaraju,et al.  Antioxidant Berberine-Derivative Inhibits Multifaceted Amyloid Toxicity , 2020, iScience.

[14]  Serdal Kirmizialtin,et al.  Designed Cell-Penetrating Peptide Inhibitors of Amyloid-beta Aggregation and Cytotoxicity , 2020 .

[15]  A. K. Mandal,et al.  Targeted inhibition of Amyloidogenesis using a non-toxic, serum stable strategically designed cyclic peptide with therapeutic implications. , 2020, Biochimica et biophysica acta. Proteins and proteomics.

[16]  C. La Rosa,et al.  Self‐Assembly and Neurotoxicity of β‐Amyloid (21–40) Peptide Fragment: The Regulatory Role of GxxxG Motifs , 2019, ChemMedChem.

[17]  M. Li,et al.  G37V mutation of Aβ42 induces a nontoxic ellipse-like aggregate: An in vitro and in silico study , 2019, Neurochemistry International.

[18]  S. Rivera,et al.  Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP , 2019, Front. Aging Neurosci..

[19]  Ozden Tacal,et al.  Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer's disease development: An up-to-date review. , 2019, European journal of pharmacology.

[20]  G. Varani,et al.  α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer’s disease , 2019, Proceedings of the National Academy of Sciences.

[21]  K. Paknikar,et al.  Inhibition of β-Amyloid Aggregation through a Designed β-Hairpin Peptide. , 2018, Langmuir : the ACS journal of surfaces and colloids.

[22]  J. Hardy,et al.  Alzheimer's disease , 2018, European journal of neurology.

[23]  Liao Y. Chen,et al.  Thermodynamics of Amyloid-β Fibril Elongation: Atomistic Details of the Transition State , 2017, ACS chemical neuroscience.

[24]  T. Willnow,et al.  Dimerization leads to changes in APP (amyloid precursor protein) trafficking mediated by LRP1 and SorLA , 2017, Cellular and Molecular Life Sciences.

[25]  Karsten Melcher,et al.  Amyloid beta: structure, biology and structure-based therapeutic development , 2017, Acta Pharmacologica Sinica.

[26]  Y. Ihara,et al.  Alanine substitutions in the GXXXG motif alter C99 cleavage by γ‐secretase but not its dimerization , 2017, Journal of neurochemistry.

[27]  R. Nussinov,et al.  Amyloid β Ion Channels in a Membrane Comprising Brain Total Lipid Extracts. , 2017, ACS chemical neuroscience.

[28]  Deepti Goyal,et al.  Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease. , 2017, ACS combinatorial science.

[29]  N. Jana,et al.  Inhibition and Degradation of Amyloid Beta (Aβ40) Fibrillation by Designed Small Peptide: A Combined Spectroscopy, Microscopy, and Cell Toxicity Study. , 2017, ACS chemical neuroscience.

[30]  John Collinge,et al.  Structural Variation in Amyloid-β Fibrils from Alzheimer’s Disease Clinical Subtypes , 2016, Nature.

[31]  S. Kahn,et al.  The S20G substitution in hIAPP is more amyloidogenic and cytotoxic than wild-type hIAPP in mouse islets , 2016, Diabetologia.

[32]  S. Prusiner,et al.  Structural Polymorphism of Alzheimer's β-Amyloid Fibrils as Controlled by an E22 Switch: A Solid-State NMR Study. , 2016, Journal of the American Chemical Society.

[33]  T. Govindaraju,et al.  Natural Tripeptide-Based Inhibitor of Multifaceted Amyloid β Toxicity. , 2016, ACS chemical neuroscience.

[34]  L. Drake,et al.  A triad of molecular regions contribute to the formation of two distinct MHC class II conformers. , 2016, Molecular immunology.

[35]  Virander S. Chauhan,et al.  C-Terminal Fragment, Aβ32-37, Analogues Protect Against Aβ Aggregation-Induced Toxicity. , 2016, ACS chemical neuroscience.

[36]  R. Tycko.  Amyloid Polymorphism: Structural Basis and Neurobiological Relevance , 2015, Neuron.

[37]  A. Boffi,et al.  β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis. , 2015, Bioorganic & medicinal chemistry.

[38]  Man Hoang Viet,et al.  In Silico and in Vitro Study of Binding Affinity of Tripeptides to Amyloid β Fibrils: Implications for Alzheimer's Disease. , 2015, The journal of physical chemistry. B.

[39]  Huaxi Xu,et al.  The γ-secretase complex: from structure to function , 2014, Front. Cell. Neurosci..

[40]  M. Kanai,et al.  A Cyclic KLVFF‐Derived Peptide Aggregation Inhibitor Induces the Formation of Less‐Toxic Off‐Pathway Amyloid‐β Oligomers , 2014, Chembiochem : a European journal of chemical biology.

[41]  R. Tycko,et al.  Locating folds of the in-register parallel β-sheet of the Sup35p prion domain infectious amyloid , 2014, Proceedings of the National Academy of Sciences.

[42]  Weijing Zhao,et al.  The molecular structure of Alzheimer β-amyloid fibrils formed in the presence of phospholipid vesicles. , 2014, Angewandte Chemie.

[43]  P. Faller,et al.  Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles. , 2014, Accounts of chemical research.

[44]  N. V. van Nuland,et al.  Transient dynamics of Aβ contribute to toxicity in Alzheimer’s disease , 2014, Cellular and Molecular Life Sciences.

[45]  Fei Li,et al.  A hIAPP‐derived all‐d‐amino‐acid inhibits hIAPP fibrillation efficiently at membrane surface by targeting α‐helical oligomeric intermediates , 2014, FEBS letters.

[46]  S. Constantinescu,et al.  Conformational changes induced by the A21G Flemish mutation in the amyloid precursor protein lead to increased Aβ production. , 2014, Structure.

[47]  Alessandro Senes,et al.  A frequent, GxxxG-mediated, transmembrane association motif is optimized for the formation of interhelical Cα–H hydrogen bonds , 2014, Proceedings of the National Academy of Sciences.

[48]  Zhi Yuan,et al.  Study on the efficiency and interaction mechanism of a decapeptide inhibitor of β-amyloid aggregation. , 2014, Biomacromolecules.

[49]  M. Karttunen,et al.  Analytical model and multiscale simulations of Aβ peptide aggregation in lipid membranes: towards a unifying description of conformational transitions, oligomerization and membrane damage. , 2013, Physical chemistry chemical physics : PCCP.

[50]  Jianxiu Wang,et al.  Kinetic studies of inhibition of the amyloid beta (1-42) aggregation using a ferrocene-tagged β-sheet breaker peptide. , 2013, Analytical biochemistry.

[51]  Ruth Nussinov,et al.  Probing ion channel activity of human islet amyloid polypeptide (amylin). , 2012, Biochimica et biophysica acta.

[52]  A. O. Andrighetti,et al.  Alpha-synuclein pore forming activity upon membrane association. , 2012, Biochimica et biophysica acta.

[53]  Ayyalusamy Ramamoorthy,et al.  Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation. , 2012, Biophysical journal.

[54]  B. Strooper,et al.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes , 2012, Nature Neuroscience.

[55]  Huaxi Xu,et al.  Proteolytic processing of Alzheimer’s β‐amyloid precursor protein , 2012, Journal of neurochemistry.

[56]  G. Multhaup,et al.  APP dimer formation is initiated in the endoplasmic reticulum and differs between APP isoforms , 2011, Cellular and Molecular Life Sciences.

[57]  I. Hamley,et al.  Amyloid peptides incorporating a core sequence from the amyloid beta peptide and gamma amino acids: relating bioactivity to self-assembly. , 2011, Chemical communications.

[58]  Younian Liu,et al.  Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro. , 2011, Bioorganic & medicinal chemistry letters.

[59]  David Eisenberg,et al.  Molecular basis for amyloid-β polymorphism , 2011, Proceedings of the National Academy of Sciences.

[60]  B. Hyman,et al.  Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.

[61]  C. Link,et al.  A glycine zipper motif mediates the formation of toxic β-amyloid oligomers in vitro and in vivo , 2011, Molecular Neurodegeneration.

[62]  K. Sugimura,et al.  A mimotope peptide of Aβ42 fibril-specific antibodies with Aβ42 fibrillation inhibitory activity induces anti-Aβ42 conformer antibody response by a displayed form on an M13 phage in mice , 2011, Journal of Neuroimmunology.

[63]  P. Wong,et al.  Amyloid precursor protein processing and Alzheimer's disease. , 2011, Annual review of neuroscience.

[64]  R. Nanga,et al.  Design of small molecules that target metal-Aβ species and regulate metal-induced Aβ aggregation and neurotoxicity , 2010, Proceedings of the National Academy of Sciences.

[65]  D. Otzen,et al.  Amyloid structure – one but not the same: the many levels of fibrillar polymorphism , 2010, The FEBS journal.

[66]  M. Benson,et al.  Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis , 2010, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[67]  A. M. Dixon,et al.  Evidence for role of transmembrane helix-helix interactions in the assembly of the Class II major histocompatibility complex. , 2010, Molecular bioSystems.

[68]  Judianne Davis,et al.  Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils , 2010, Nature Structural &Molecular Biology.

[69]  D. Mann,et al.  Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease. , 2010, Biochemistry.

[70]  K. MacKenzie,et al.  Intermonomer hydrogen bonds enhance GxxxG-driven dimerization of the BNIP3 transmembrane domain: roles for sequence context in helix-helix association in membranes. , 2010, Journal of molecular biology.

[71]  R. Kirubagaran,et al.  Surfactant-induced conformational transition of amyloid β-peptide , 2009, European Biophysics Journal.

[72]  Boris Martinac,et al.  Ion channels in microbes. , 2008, Physiological reviews.

[73]  G. Bitan,et al.  C-terminal peptides coassemble into Aβ42 oligomers and protect neurons against Aβ42-induced neurotoxicity , 2008, Proceedings of the National Academy of Sciences.

[74]  J. Bowie,et al.  Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutants , 2008, BMC Neuroscience.

[75]  B. Austen,et al.  Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide. , 2008, Biochemistry.

[76]  C. Masters,et al.  Membrane interactions and the effect of metal ions of the amyloidogenic fragment Aβ(25–35) in comparison to Aβ(1–42) , 2007 .

[77]  J. Díaz,et al.  Aβ ion channels. Prospects for treating Alzheimer's disease with Aβ channel blockers , 2007 .

[78]  D. Selkoe,et al.  Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.

[79]  G. Multhaup,et al.  GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Aβ42 , 2007 .

[80]  G. Melacini,et al.  Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy. , 2007, Journal of the American Chemical Society.

[81]  D Thirumalai,et al.  Monomer adds to preformed structured oligomers of Aβ-peptides by a two-stage dock–lock mechanism , 2007, Proceedings of the National Academy of Sciences.

[82]  Andrew F Hill,et al.  Delineating common molecular mechanisms in Alzheimer's and prion diseases. , 2006, Trends in biochemical sciences.

[83]  S. Constantinescu,et al.  Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42. , 2006, Biochemistry.

[84]  Tae-Joon Jeon,et al.  Transmembrane glycine zippers: physiological and pathological roles in membrane proteins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[85]  Hai Lin,et al.  Amyloid ion channels: a common structural link for protein-misfolding disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[86]  G. Westermark,et al.  Inhibition of hIAPP amyloid-fibril formation and apoptotic cell death by a designed hIAPP amyloid- core-containing hexapeptide. , 2005, Chemistry & biology.

[87]  V. Marchesi,et al.  An alternative interpretation of the amyloid Abeta hypothesis with regard to the pathogenesis of Alzheimer's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[88]  Huilin Li,et al.  Structural Role of Glycine in Amyloid Fibrils Formed from Transmembrane α-Helices† , 2005 .

[89]  B. Penke,et al.  Beta-amyloid-derived pentapeptide RIIGLa inhibits Abeta(1-42) aggregation and toxicity. , 2004, Biochemical and biophysical research communications.

[90]  Jason E Gestwicki,et al.  Harnessing Chaperones to Generate Small-Molecule Inhibitors of Amyloid ß Aggregation , 2004, Science.

[91]  O. Ashur-Fabian,et al.  The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide , 2003, Peptides.

[92]  A. Dautant,et al.  The GxxxG motif of the transmembrane domain of subunit e is involved in the dimerization/oligomerization of the yeast ATP synthase complex in the mitochondrial membrane. , 2003, European journal of biochemistry.

[93]  David Eisenberg,et al.  GXXXG and AXXXA: Common α-Helical Interaction Motifs in Proteins, Particularly in Extremophiles† , 2002 .

[94]  B. Penke,et al.  Pentapeptide amides interfere with the aggregation of beta-amyloid peptide of Alzheimer's disease. , 2002, Biochemical and biophysical research communications.

[95]  R. Lal,et al.  Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[96]  L. Kiessling,et al.  Structure-function relationships for inhibitors of beta-amyloid toxicity containing the recognition sequence KLVFF. , 2001, Biochemistry.

[97]  T. Grabowski,et al.  Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy , 2001, Annals of neurology.

[98]  R. Leapman,et al.  Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of β-sheets in Alzheimer's β-amyloid fibrils , 2000 .

[99]  B. Strooper,et al.  Proteolytic processing and cell biological functions of the amyloid precursor protein. , 2000, Journal of cell science.

[100]  M. Gerstein,et al.  Statistical analysis of amino acid patterns in transmembrane helices: the GxxxG motif occurs frequently and in association with beta-branched residues at neighboring positions. , 2000, Journal of molecular biology.

[101]  D. Engelman,et al.  The GxxxG motif: a framework for transmembrane helix-helix association. , 2000, Journal of molecular biology.

[102]  T. Harkany,et al.  Propionyl-IIGL tetrapeptide antagonizes beta-amyloid excitotoxicity in rat nucleus basalis. , 1999, Neuroreport.

[103]  H. Shao,et al.  Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease. , 1999, Journal of molecular biology.

[104]  T. Benzinger,et al.  Propagating structure of Alzheimer’s β-amyloid(10–35) is parallel β-sheet with residues in exact register , 1998 .

[105]  C. Broeckhoven,et al.  Flemish and Dutch Mutations in Amyloid β Precursor Protein Have Different Effects on Amyloid β Secretion , 1998, Neurobiology of Disease.

[106]  D. Craik,et al.  Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? , 1998, Biochemistry.

[107]  Claudio Soto,et al.  β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy , 1998, Nature Medicine.

[108]  D. Engelman,et al.  A Transmembrane Helix Dimer: Structure and Implications , 1997, Science.

[109]  B. Kagan,et al.  Channel Formation by a Neurotoxic Prion Protein Fragment* , 1997, The Journal of Biological Chemistry.

[110]  C. Soto,et al.  Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. , 1996, Biochemical and biophysical research communications.

[111]  T. Sanke,et al.  Missense Mutation of Amylin Gene (S20G) in Japanese NIDDM Patients , 1996, Diabetes.

[112]  L. Tjernberg,et al.  Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand (*) , 1996, The Journal of Biological Chemistry.

[113]  B. Kagan,et al.  Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin (*) , 1996, The Journal of Biological Chemistry.

[114]  S. Jones,et al.  Principles of protein-protein interactions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[115]  T. Torgerson,et al.  Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence (*) , 1995, The Journal of Biological Chemistry.

[116]  P. S. Kim,et al.  Measurement of the β-sheet-forming propensities of amino acids , 1994, Nature.

[117]  D. Engelman,et al.  Sequence specificity in the dimerization of transmembrane alpha-helices. , 1992, Biochemistry.

[118]  I. Lieberburg,et al.  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[119]  V. Marchesi,et al.  Subunit structure of human erythrocyte glycophorin A. , 1976, Biochemistry.

[120]  B. de Strooper,et al.  Presenilins and γ-secretase: structure, function, and role in Alzheimer Disease. , 2012, Cold Spring Harbor perspectives in medicine.

[121]  Daniel R. Caffrey,et al.  Structure-based maximal affinity model predicts small-molecule druggability , 2007, Nature Biotechnology.

[122]  R. Leapman,et al.  A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[123]  F E Cohen,et al.  Pathologic conformations of prion proteins. , 1998, Annual review of biochemistry.

[124]  J. Pollard,et al.  T-cell antigen receptor transmembrane peptides modulate T-cell function and T cell-mediated disease , 1997, Nature Medicine.

[125]  D. Selkoe,et al.  Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. , 1994, Annual review of cell biology.

[126]  A. Hofman,et al.  Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene , 1992, Nature Genetics.